Lebanese Forces: Man Beats Cancer for 8 Years

A 76-year-old British patient managed to survive for eight years after being diagnosed with high-risk multiple myeloma, thanks to the success of a clinical trial involving personalized treatment using a combination of five drugs and stem cell transplantation. Physicians' initial prognosis suggested he would only survive for two years, but the standard treatment yielded remarkable results: the study showed that 70% of participants were still alive after six years, with 54% remaining disease-free. The therapy focuses on customizing treatment based on genetic information through a genetic test called MMProfiler SKY92, which helps improve the chances of controlling the disease and achieving better outcomes.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل